tenomir
Nucleic acidexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 14, 2020 (NCT04670289)
Timeline
Indications
Studied for
Mechanism of action
- MicroRNA 29Supplementation
MicroRNA 29 supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06192927 | Phase 2 | Apr 10, 2024 | Causeway Therapeutics |
| NCT04670289 | Phase 1 | Aug 14, 2020 | Causeway Therapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Causeway Therapeutics | For profit | 2 | 2 | 2 | 2020 |
1 organizations
Page 1 / 1